O objetivo do presente estudo foi avaliar a associação entre lesões de cárie dentária e defeitos do desenvolvimento do esmalte (DDEs) com o índice de massa corporal e com polimorfismos nos genes que codificam as metaloproteinases 8, 13 e 20, em uma população de crianças amazônicas. A amostra foi constituída de 221 crianças, com idade entre 9 e 12 anos, de ambos os gêneros, matriculadas em quatro escolas públicas da cidade de Manaus - Amazonas. Durante o exame clínico foram obtidos os índices CPO-D e/ou ceo-d, dados referentes aos DDEs e dados antropométricos (peso e altura). Os responsáveis responderam a um questionário sobre hábitos de higiene bucal e dieta. Amostras de saliva foram coletadas como fonte de DNA genômico e, por meio do método Taqman, por PCR em tempo real, realizou-se a genotipagem das regiões rs17099443 e rs3765620 no gene que codifica a MMP8; rs478927 e rs2252070 no gene que codifica a MMP13; e rs1784418 no gene que codifica a MMP20. Os dados foram submetidos à análise estatística empregando os testes de Shapiro-Wilk, ANOVA, Tukey, Qui-quadrado, Exato de Fisher e a razão de chance, com nível de significância de 5%. De acordo com os resultados obtidos verificou-se que, nas crianças com baixo peso, a média de lesões de cárie dental foi 1,00 (DMP 1,00), nas eutróficas a média de lesões de cárie dental foi de 1,57 (DMP 2,00), nas com sobrepeso, a média foi de 1,44 (DMP 1,86) e nas crianças obesas foi de 3,12 (DMP 2,63). Crianças obesas apresentaram mais lesões de cárie que as crianças eutróficas e com sobrepeso (p<0,05). Nos genes que codificam MMP8, MMP13 e MMP20 os alelos polimórficos foram observados em maior frequência nos indivíduos com experiência de cárie, com associação significativa apenas para o polimorfismo rs478927 no gene que codifica a MMP13 (p=0,043). Com relação aos DDE, os alelos polimórficos foram observados em maior frequência nos genes que codificam MMP8, MMP13 e MMP20, com associação significativa apenas para o polimorfismo rs478927 no gene que codifica a MMP13 (p=0,005). Para o gene que codifica MMP13, houve diferença significativa na distribuição dos genótipos entre os grupos controle e DDE (p=0,017). Com base nos parâmetros analisados e nos resultados obtidos, foi possível concluir que, em crianças de Manaus-AM, as lesões de cárie estiveram associadas com obesidade, e que houve associação entre o polimorfismo genético (rs478927) no gene que codifica a MMP13 com presença de lesões de cárie e DDEs / The objective of the present study was to evaluate the association between dental caries lesions and developmental enamel defects (DED) with body mass index and polymorphisms in gene encoding matrix metalloproteinases 8, 13 and 20 in a population of Amazonian children. The sample consisted of 221 children, aged between 9 and 12 years, of both genders, regularly enrolled in four public schools in the city of Manaus, Amazonas State, Brazil. During the clinical examination, the researchers recorded DMFT and/or dmft indexes, DED data and anthropometric data (weight and height). Parents/caregivers answered a questionnaire about children´s oral hygiene habits and diet. Saliva samples were collected as a source of genomic DNA and, using TaqMan real-time PCR, genotyping was performed of regions rs17099443 and rs3765620 in the gene encoding MMP8; rs478927 and rs2252070 in the gene encoding MMP13; and rs1784418 in the gene encoding MMP20. Data were submitted to statistical analysis using the Shapiro-Wilk, ANOVA, Tukey, Qui-quadrado, Exato de Fisher and odds ratio tests, with a significance level of 5%. According to the results, it was found that, in children with low weight, the mean number of dental caries lesions was 1.00 (SD 1.00); in the eutrophic children the mean was 1.57 (SD 2.00); in the overweight children, the mean was 1.44 (SD 1.86) and in obese children the mean was 3.12 (SD 2.63). Obese children had more dental caries lesions than eutrophic and overweight children (p<0.05). In the genes encoding MMP8, MMP13 and MMP20, the polymorphic alleles were observed more frequently in individuals with caries experience, with a significant association only for rs478927 polymorphism in the gene encoding MMP13 (p=0.043). With respect to DED, the polymorphic alleles were observed more frequently in the genes encoding MMP8, MMP13 and MMP20, with a significant association only for the rs478927 polymorphism in the gene encoding MMP13 (p=0.005). There was a significant difference in the distribution of genotypes between the control and DED groups (p = 0.017) for the gene encoding MMP13. Based on the analyzed parameters and the obtained results, it was possible to conclude that in children from Manaus-AM, caries lesions are associated with obesity, and that there was an association between gene polymorphism (rs478927) in the gene encoding MMP13 with presence of caries lesions and DED

Abstract Matrix metalloproteinases (MMPs) are the zinc-dependent endopeptidases which belong to a large family of proteases. MMPs are responsible for degradation and remodeling of extracellular matrix proteins during growth, organogenesis and tissue turnover. Besides their role in physiological processes, MMPs also influence various pathological processes, i.e., inflammatory diseases and cancers, in which MMPs may ultimately lead to unwanted tissue destruction. One of the most widely studied MMPs is MMP-8. MMP-8 was previously thought to be expressed only by neutrophils. Presently, it is evident that MMP-8 can be expressed in a wide range of cells such as macrophages, plasma cells, T-cells, endothelial cells, smooth muscle cells, oral epithelial cells, fibroblasts etc. MMP-8 has been previously studied in inflammation and malignancies. High serum MMP-8 concentration is associated with the presence of atherosclerosis and poor cardiovascular disease prognosis, while higher plasma MMP-8 levels protect against lymph node metastasis. Certain MMP-8 gene variations can alter promoter activity and subsequent gene expression. MMP-8 gene variation influences obstetrical outcomes, and lung and breast cancer prognosis. For our study, we hypothesized that systemic levels of MMP-8 correlate with its genetic variations and appear as novel risk markers for disease. We aimed to address the potential role of MMPs and their regulators with a special focus on MMP-8 in distinct sets of inflammatory and malignant diseases, i.e. arterial diseases, and head and neck squamous cell cancer (HNSCC). We demonstrated that the combination of high serum MMP-8 and low myeloperoxidase (MPO) levels is an important risk marker for arterial disease. Further, we demonstrated that MMP-8 gene variation is protective against arterial diseases. Interestingly, we were able to demonstrate an association between MMP-8 gene variation and serum MMP-8 concentration in a healthy population. On the other hand, we showed that plasma tissue inhibitor of matrix metalloproteinases (TIMP-1) concentration is associated with survival in HNSCC patients and TIMP-1 genotype is associated with plasma TIMP-1 levels in women only. Collectively, our study showed that serum MMP-8 levels can be used as an important risk marker in arterial disease and TIMP-1 levels in HNSCC patients. Based on our results, the hypothesis raised has been widely confirmed. Additionally, our study has warranted the need for further investigation involving a larger number of patients. If our results are replicable, serum MMP-8 and plasma TIMP-1 could be used to develop diagnostic tools as well as treatment regimes in clinics. / Tiivistelmä Matriksin metalloproteinaasit (MMP:t) ovat sinkkiriippuvaisia endopeptidaaseja, jotka kuuluvat laajaan proteiineja pilkkovaan proteolyyttiseen entsyymi perheeseen. MMP:ien tehtävä on pilkkoa ja uudelleen muokata soluväliaineen proteiineja kasvun, elinten kehityksen ja kudosten uusiutumisen aikana, mutta MMP:t toimivat aktiivisesti myös patologisissa prosesseissa, kuten tulehdustiloissa ja syövissä. Syövissä MMP:en vaikutus voi johtaa ei-toivottuun kudostuhoon. Yksi laajimmin tutkituista MMP-ryhmän entsyymeistä on MMP-8, jonka alunpitäen ajateltiin ilmenevän vain neutrofiileissä. Nykytietämyksen mukaan MMP-8:aa ilmentyy myös mm. makrofaageissa, plasmasoluissa, T-soluissa, endoteelisoluissa, sileälihassoluissa, suun limakalvon epiteelisoluissa ja fibroplasteissa. MMP-8:aa on aikaisemmin tutkittu erityisesti tulehdustiloissa ja pahanlaatuisissa kasvaimissa. Korkean MMP-8 seerumipitoisuuden on havaittu liittyvän valtimokovettumatautiin ja huonoon ennusteeseen sydän- ja verisuonisairauksissa, kun taas kohonnut MMP-8:n pitoisuus plasmassa suojaa imusolmuke-etäpesäkkeiltä. Tiedetään, että tietyt muutokset MMP-8:n geenissä voivat muuttaa sen promoottoriaktiviteettia ja täten säädellä geenin ilmentymistä. MMP-8:n geenimuutokset vaikuttanevat raskaudenkulkuun sekä keuhko- ja rintasyövän ennusteeseen. Tutkimushypoteesimme mukaan MMP-8:n seerumipitoisuudet riippuvat vaihtelusta MMP-8:aa koodaavassa geenissä ja niitä voidaan pitää uusina riskinarvioinnin merkkiaineina tautitiloissa. Tavoitteenamme oli osoittaa yleisesti MMP:ien ja erityisesti MMP-8:n sekä näiden proteinaasien säätelytekijöiden merkitys tietyissä tulehdustiloissa ja maligniteeteissa, kuten sepelvaltimotaudissa ja pään ja kaulan alueen syövissä. Havaitsimme, että korkea MMP-8 seerumipitoisuus ja alhainen myeloperoksidaasitaso yhdistyvät vahvasti valtimotautiriskiin. Lisäksi osoitimme, että tietty MMP-8:n geenimuunnos on suojaava tekijä valtimotaudille ja että MMP-8:n seerumikonsentraatio on siitä riippuvainen terveillä tutkituilla. Tämän lisäksi todensimme, että MMP:n kudosestäjän (tissue inhibitor of matrix metalloproteinases, TIMP-1) plasmapitoisuus liittyy pään ja kaulan alueen levyepiteelisyöpää sairastavien potilaiden eloonjääntiin ja että TIMP-1:n genotyyppi liittyy sen plasmapitoisuuteen ainoastaan naisilla. Tulostemme mukaan seerumin MMP-8-pitoisuutta voidaan pitää hyvänä riskinarviointivälineenä verisuonitaudeissa sekä TIMP-1-pitoisuutta vastaavasti pään ja kaulan alueen levyepiteelisyövissä. Saadut tulokset tukevat olettamustamme, jonka mukaan MMP-8 on tärkeä tautimarkkeri. Tämä on lisännyt kiinnostusta selvittää MMP:ien merkitystä laajemmin muissa tulehdustiloissa ja syövissä. Jos tulokset saadaan toistetuksi laajemmassa tutkimusaineistossa, seerumin MMP-8:sta voidaan kehittää kliinisten ja analyyttisten laboratorioiden käyttöön sopiva diagnostinen menetelmä.

No description available.